Regulatory-processResearch-and-developmentOsteogenic-protein-1, therapeutic useFracture, treatmentInpharma Weekly -doi:10.2165/00128413-200112760-00061NoneSpringer International PublishingInpharma Weekly
The Cascadia Lateral 3D cages are built with Lamellar 3D Titanium Technology, which incorporates 500μm longitudinal channels throughout the implant, which in conjunction with transverse windows, create an interconnected lattice design to allow for bony integration.6 LEARN MORE Everest MI XT The ...
1,2 According to The UK National Joint Registry: MRH demonstrated 93.9% survivorship at 10 years post op.3 Resources Triathlon Hinge Sell Sheet Triathlon Hinge Surgical Protocol Stryker’s Revision Knee Clinical Evidence Request More Info Contact us Send us a message to learn more about ...
斯特里克（Stryker）逆向肩关节置换说明书 Tornier BIO-RSA®System overview
In order to best size and fit the tibial implant, start by setting the desired proudness value (typically 3mm) and the sagittal tibial slope to match the native anatomical slope of the patient denoted by the magenta line (Figure 1) . For a very steep native slope, stay at the maximum re...
whether it’s Q Guidance or whether it’s implant launches or system launches or investments that you are making, can you talk about maybe anything that you would see as kind of gradually driving up momentum in that business as you head into -- as you get into that introduction of the ...
SpeedAkin provides an anatomic implant with dynamic titanium compression to stabilize the Akin osteotomy during healing. By: Sam Brusco OEM News Zimmer Biomet to Buy Paragon 28 for $1.2 Billion Paragon 28 touts a suite of surgical offerings and product systems spanning all ma...
One such area was biotechnology. In 1985, Stryker entered into a long-term collaborative research program with Creative BioMolecules, Inc. The purpose of the collaboration was to develop an implant that utilized an osteogenic protein. The protein, OP-1, occurred naturally in humans and helped to...
The invention also provides an implantable prosthetic device comprising a prosthetic implant having a surface region, a porous β-TCP material disposed on the surface region and optionally comprising at least a bioactive agent or a binder. Methods of producing the porous β-TCP material and inducing...
Orthopedics | Stryker Corporation announced yesterday the closing of the previously announced sale of its OP-1 product family, which includes OP-1 Implant, OP-1 Putty, Opgenra and Osigraft, for use in orthopedic bone applications to the Olympus Corporation. The transaction also include...